Answers are grounded in this paper and cite their sources.
Activator protein-1 (AP-1) is a critical transcription factor complex involved in tumor progression by regulating genes associated with proliferation, migration, and survival. Among its components, c-Fos plays a pivotal role in determining AP-1 transcriptional output, making it a key regulatory node for understanding upstream modulation of AP-1 signaling. However, the upstream deubiquitinating enzymes (DUBs) that regulate c-Fos protein stability and thereby modulate AP-1 activity remain incompletely defined. A systematic screen using a human DUB expression library was performed to identify DUBs that regulate c-Fos. Biochemical and cell-based assays evaluated USP2-c-Fos interaction, ubiquitination, deubiquitination, protein stability, subcellular abundance, and transcriptional activity. Immunocytochemistry was used to assess single-cell protein-level associations. Transcriptomic analyses, c-Fos ChIP-qPCR, VEGFA secretion assays, and breast cancer cell growth, migration, and invasion assays were used to evaluate transcriptional and phenotypic effects. TCGA breast cancer data were analyzed to assess the relationship between USP2 expression and AP-1 transcriptional signatures. USP2 was identified as a DUB that interacts with the basic leucine zipper (bZIP) domain of c-Fos and directly reduces its ubiquitination in a catalytic activity-dependent manner. USP2 increased c-Fos protein stability, nuclear abundance, and AP-1-dependent transcriptional activity, whereas genetic depletion or pharmacological inhibition of USP2 attenuated these effects. Single-cell immunocytochemical analysis revealed a positive association between USP2 and c-Fos protein levels. Transcriptomic analyses of USP2-deficient breast cancer cells revealed coordinated changes in gene expression, including attenuation of AP-1-associated transcriptional programs, which significantly overlapped with transcriptional changes following FOS depletion in an independent dataset. USP2 depletion also reduced c-Fos occupancy at selected AP-1-responsive promoters and decreased VEGFA secretion. Functionally, USP2 depletion reduced breast cancer cell growth, migration, and invasion, whereas c-Fos re-expression partially rescued these phenotypes. In human breast tumors, USP2 expression was positively associated with AP-1 transcriptional signatures. These findings identify USP2 as a key post-translational regulator of c-Fos, linking c-Fos deubiquitination and protein stability to AP-1-associated transcriptional and cellular programs in breast cancer.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: